ARLN and neoplasm: In univariate analysis, compared with patients in ALN− group, patients in ALN+ group were more likely to have larger tumor size on pathology (>2 cm) (80.49% vs 64.48%, P = .037) and multifocal lesions (9.76% vs 3.37%, P = .039).